Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Forma To Rev Its Discovery Engine For Deubiquitination

Jul 09 2013

• By Alex Lash

Related Content

With Celgene Deal, Forma Makes First Foray Into Clinical Development

Apr 29 2013

New $80 Million U.K. Asset-Centric Cancer Research Fund Set Up With EU, Charity Funding

Mar 29 2012

Forma To Play To Its Strengths WIth Genentech Deal

Jul 01 2011

The Next Big Thing In Drug Development May Be The Ubiquitin Pathway

Apr 01 2010

Related Companies

Forma Therapeutics Inc.

Cancer Research Horizons

Cancer Research UK

Arteaus Therapeutics, LLC

Drais Pharmaceuticals, Inc.

Takeda Pharmaceutical Co. Ltd.

Cancer Research UK

Boehringer Ingelheim GmbH

Johnson & Johnson

Roche Holding AG

Genentech, Inc.

City of Hope

Additional Topics

United Kingdom Europe United States Strategy Deals Business Strategies Innovation BioPharmaceutical

More from United Kingdom

More from Europe

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window